688050 Stock Overview
Eyebright Medical Technology (Beijing) Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Eyebright Medical Technology (Beijing) Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥90.28 |
| 52 Week High | CN¥118.00 |
| 52 Week Low | CN¥65.17 |
| Beta | 0.52 |
| 11 Month Change | -10.89% |
| 3 Month Change | 19.10% |
| 1 Year Change | -15.59% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -34.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688050 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -3.1% | -2.1% | -2.8% |
| 1Y | -15.6% | -11.8% | 2.0% |
Return vs Industry: 688050 underperformed the CN Medical Equipment industry which returned -11.8% over the past year.
Return vs Market: 688050 underperformed the CN Market which returned 2% over the past year.
Price Volatility
| 688050 volatility | |
|---|---|
| 688050 Average Weekly Movement | 10.4% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 688050 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688050's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 2,091 | Jiangbing Xie | www.ebmedical.com |
Eyebright Medical Technology (Beijing) Co., Ltd. develops a range of ophthalmic medical products. Its products include surgical implants and instruments, equipment, optometric lenses, eye drops, etc. for the treatment of ophthalmic diseases and vision problems, such as cataract, glaucoma, refractive errors, and other ophthalmic diseases.
Eyebright Medical Technology (Beijing) Co., Ltd. Fundamentals Summary
| 688050 fundamental statistics | |
|---|---|
| Market cap | CN¥17.11b |
| Earnings (TTM) | CN¥369.60m |
| Revenue (TTM) | CN¥1.36b |
46.3x
P/E Ratio12.6x
P/S RatioIs 688050 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688050 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.36b |
| Cost of Revenue | CN¥451.64m |
| Gross Profit | CN¥906.70m |
| Other Expenses | CN¥537.10m |
| Earnings | CN¥369.60m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.95 |
| Gross Margin | 66.75% |
| Net Profit Margin | 27.21% |
| Debt/Equity Ratio | 24.2% |
How did 688050 perform over the long term?
See historical performance and comparison